Treeline Biosciences is a privately held, clinical-stage biopharmaceutical company dedicated to developing innovative treatments for cancer and other serious diseases. Utilizing advanced computational tools and proven drug approaches, Treeline focuses on creating therapies that target compelling disease mechanisms. The company's pipeline includes small molecules, protein degraders, and targeted therapy antibody-drug conjugates (ADCs), with current programs addressing conditions such as lymphoma and KRAS-mutated cancers. Led by experienced oncologists and R&D leaders, Treeline operates across the U.S. and Europe, aiming to redefine treatment paradigms in oncology and beyond.
Leadership & Board
Key Executives
- SVP Corporate Development
- Spencer Smith
- Co-Founder & CSO
- Jeffrey Engelman
- CEO & Co-Founder
- Josh Bilenker
- Current Number of Employees
- 174
- Current LinkedIn Followers
- 11,763
Latest Estimated Valuation
- Total Amount Raised
- $200M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $200M
- Latest Funding Round
- Series A
Employee Trend
Treeline Biosciences had 174 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Treeline Biosciences had 11,763 followers as of October 26, 2026. The number of followers increased by 38 (0.32%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 03, 2025 | Series A | $200.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| OrbiMed | Series A |
| T. Rowe Price Associates, Inc. | Series A |
| Fidelity Management & Research Company | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| KKR | Series A |
| AI Life Sciences | Series A |
| Ajax Health/Zeus | Series A |
Similar Companies
A snapshot of private companies similar to Treeline Biosciences, helping you discover and navigate related company profiles.
